|
US6307047B1
(en)
|
1997-08-22 |
2001-10-23 |
Abbott Laboratories |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors
|
|
CN1142148C
(zh)
|
1997-11-19 |
2004-03-17 |
兴和株式会社 |
新颖的哒嗪衍生物和含有其作为有效成分的药物
|
|
TWI241295B
(en)
|
1998-03-02 |
2005-10-11 |
Kowa Co |
Pyridazine derivative and medicine containing the same as effect component
|
|
JP2003512292A
(ja)
*
|
1998-10-27 |
2003-04-02 |
アボット・ラボラトリーズ |
プロスタグランジンエンドペルオキシドｈシンターゼ生合成阻害剤
|
|
JP2000247959A
(ja)
|
1999-02-26 |
2000-09-12 |
Kowa Co |
ピリダジン−３−オン誘導体及びこれを含有する医薬
|
|
DE60016191T2
(de)
|
1999-12-08 |
2005-12-22 |
Pharmacia Corp., Chicago |
Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt
|
|
RU2002119574A
(ru)
|
1999-12-23 |
2004-01-10 |
Нитромед, Инк. (Us) |
Нитрозированные и нитрозилированные ингибиторы циклооксигеназы-2, композиции на их основе и способы их применения
|
|
US6664256B1
(en)
|
2000-07-10 |
2003-12-16 |
Kowa Co., Ltd. |
Phenylpyridazine compounds and medicines containing the same
|
|
AR038957A1
(es)
|
2001-08-15 |
2005-02-02 |
Pharmacia Corp |
Terapia de combinacion para el tratamiento del cancer
|
|
WO2004002420A2
(en)
|
2002-06-28 |
2004-01-08 |
Nitromed, Inc. |
Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
|
|
BRPI0408359A
(pt)
|
2003-03-18 |
2006-03-21 |
Kowa Co |
derivados de fenilpiridazina solúveis em água e medicamentos contendo os mesmos
|
|
EP1534305B9
(en)
|
2003-05-07 |
2007-03-07 |
Osteologix A/S |
Treating cartilage / bone conditions with water-soluble strontium salts
|
|
WO2005012259A1
(ja)
*
|
2003-07-30 |
2005-02-10 |
Kowa Co., Ltd. |
オステオポンチン産生抑制方法
|
|
DE102004010207A1
(de)
*
|
2004-03-02 |
2005-09-15 |
Aventis Pharma S.A. |
Neue 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate
|
|
ES2524922T3
(es)
|
2005-05-10 |
2014-12-15 |
Intermune, Inc. |
Derivados de piridona para modular el sistema de proteína cinasa activada por estrés
|
|
DE102005057924A1
(de)
*
|
2005-12-05 |
2007-06-06 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
DE102006037478A1
(de)
*
|
2006-08-10 |
2008-02-14 |
Merck Patent Gmbh |
2-(Heterocyclylbenzyl)-pyridazinonderivate
|
|
DE102007025718A1
(de)
*
|
2007-06-01 |
2008-12-04 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
JP5627574B2
(ja)
|
2008-06-03 |
2014-11-19 |
インターミューン， インコーポレイテッド |
炎症性および線維性疾患を治療するための化合物および方法
|
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
|
MX382781B
(es)
|
2014-04-02 |
2025-03-13 |
Intermune Inc |
Piridinonas anti-fibroticas.
|
|
WO2018049027A1
(en)
|
2016-09-07 |
2018-03-15 |
Trustees Of Tufts College |
Combination therapies using immuno-dash inhibitors and pge2 antagonists
|
|
WO2022195579A1
(en)
|
2021-03-15 |
2022-09-22 |
Saul Yedgar |
Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases
|